|Dr. Michael K. Korenko||CEO, Pres & Director||120k||N/A||1946|
|Dr. Carlton M. Cadwell||Independent Chairman & Sec.||N/A||N/A||1945|
|Mr. Michael H. Pollack CPA, CPA||Chief Financial Officer||N/A||N/A||1966|
|Dr. David J. Swanberg M.S., P.E.||Chief Technical Mang.||N/A||N/A||1957|
|Dr. Nigel R. Stevenson||Chief Science Officer||N/A||N/A||N/A|
|Dr. Fu-Min Su||Chief Radio Chemist & Radiation Safety Officer||N/A||N/A||N/A|
Vivos Inc., a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for animals. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc. in December 2017. Vivos Inc. was incorporated in 1994 is headquartered in Richland, Washington.
Vivos Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.